Details of the Drug Combinations

General Information of This Drug (ID: DM4LNBQ)

Drug Name

Pyroxamide DM4LNBQ

Synonyms

POLAR HYBRID COMPOUND; Suberoyl-3-aminopyridineamide hydroxamic acid; N-Hydroxy-N'-3-pyridinyloctanediamide; N'-hydroxy-N-pyridin-3-yloctanediamide; N-hydroxy-n'-(pyridin-3-yl)octanediamide; N-Hydroxy-N'-(3-pyridyl)-1,8-octanediamide

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Discontinued in Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

3 Investigative Drug Combination(s) Consisting of This drug

Normalized Drug Combination Synergy Score

Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Pyroxamide + Panobinostat	DCKK67B	Panobinostat	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[2]
Pyroxamide + Marizomib	DCMHHPG	Marizomib	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[2]
Pyroxamide + Ruxolitinib	DC0V4EP	Ruxolitinib	Hodgkin lymphoma (Cell Line: L-1236)	[3]
------------------------------------------------------------------------------------

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018698)
2	CheMBL Affinity Phenotypic Cellular Interaction Assay ID: CHEMBL1125966
3	CheMBL Affinity Phenotypic Cellular Interaction Assay ID: CHEMBL1125976